ExodusPoint Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
ExodusPoint Capital Management's PCVX Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 42,357 shares — an estimated $2.46M sold.
ExodusPoint Capital Management first reported a position in PCVX in Q3 2021 and held it in 3 quarters. The position peaked at $7.31M in Q1 2026. 353 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- ExodusPoint Capital Management reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 42,357 Vaxcyte shares in Q3 2026, an estimated $2.46M.
- ExodusPoint Capital Management first reported a position in Vaxcyte in Q3 2021 and held it in 3 quarters.
- ExodusPoint Capital Management's Vaxcyte position peaked at $7.31M in Q1 2026.
- 353 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.